Vitalhub Corp. · TSX:VHI
Vitalhub — Investor Presentation (August 2026)
22 slides from Vitalhub's investor presentation, August 2026
Slide 1: Investor presentation
Investor presentation August 2026 TSX:VHI OTCQX:VHIBF
Slide 2: Disclaimer
Disclaimer This Corporate Presentation (the “Presentation”) has been prepared by management of Vitalhub Corp. (“VitalHub” or the “Company”) and is based on public information and the Company’s confidential information. This Presentation is for information purposes only and is being made available on
Slide 3: Who We Are
Who We Are VitalHub is a leading software company dedicated to empowering Health and Human Services providers Established in 2016 1,300+ customers Headquartered in Toronto Across the UK, Canada, and other regions 700+ employees Coast to coast footprint Including offshore Innovations Lab Trusted nati
Slide 4: Healthcare Software | Total Addressable Market
Healthcare Software | Total Addressable Market Focus on single-payer regions with an increasing emphasis on digital transformation $10 billion Focus region Total health spend opportunity The UK £180B (1) across the UK, Canada, Australia, Canada $350B (2) and the Mid-East Australia A$140B (3) assumin
Slide 5: Healthcare Software | Product Portfolio
Healthcare Software | Product Portfolio Flow Manager | Check-in Regional Capacity Planning SHREWD Patient Engagement Portal Patient Flow & Patient App | Clinical Portal Pre-Op Assessment Operational Mobile and Kiosk Check-in Visibility eReferral | Waitlist Management Waiting List Validation Zesty |
Slide 6: Healthcare Software | Artificial Intelligence
Healthcare Software | Artificial Intelligence Health and Human Services Revenue Opportunities Margin Expansion Empower Trusted Providers Capture AI Budgets Increase Productivity Healthcare institutions need an Smart Medical Scribing Code Development Care Coordination Generation and QA established pa
Slide 7: Healthcare Software | VitalHub Innovations Lab
Healthcare Software | VitalHub Innovations Lab Offshore Sri Lankan team centralizes core functions, allowing VitalHub to scale effectively Founded in 2007 220+ developers, engineers and quality assurance professionals Learn more online: YOUTUBE and LINKEDIN 7
Slide 8: Mergers & Acquisitions | Strategy
Mergers & Acquisitions | Strategy Synergistic consolidation strategy with a clearly defined framework for increasing growth and profitability Consolidate G&A Cost-Effective R&D Optimize S&M Grow Together Centralized systems, resources, The Innovations Lab increases Global coordination of regional Co
Slide 9: Mergers & Acquisitions | Model
Mergers & Acquisitions | Model 1.0-2.5x $2-20M $0+ 400+ Revenue Multiple Annual Revenue Breakeven or Global Pipeline Profitable 4-7 Year 60%+ 20%+ VHI Cash Payback Recurring Revenue Adj. EBITDA Combination of Margin Target Cash and Stock 9
Slide 10: Mergers & Acquisitions | Summary
Mergers & Acquisitions | Summary 24 Completed acquisitions (1) By Geography By Segment $210M+ Patient Flow & Total capital raised Canada 9 Operational Visibility 15 EHR, Case $195M+ Total capital deployed The UK 13 Management & Care 7 Coordination $120M+ Workforce Automation Net cash on hand RoW 2 &
Slide 11: Mergers & Acquisitions | History
Mergers & Acquisitions | History 2017 2018 2018 2018 2019 2019 2020 2020 2021 2021 2021 2022 2022 2022 2022 2023 2024 2024 2024 2024 2025 2025 2025 2026 Patient Flow EHR, Case Management Workforce Automation & Operational Visibility & Care Coordination & Compliance 11
Slide 12: Financial Performance | Highlights
Financial Performance | Highlights $101.5M $31.7M 100%+ 79% ARR Total Quarterly Net Revenue Gross Margin (1) Revenue (1) Retention +10% +33% 3-6% 26% Organic ARR Total Revenue Gross Annual Adj. EBITDA Growth (1) Growth (1) Churn Margin (1) (1) For the quarter ended June 30, 2026, variances year over
Slide 13: Financial Performance | Annual Recurring Revenue
Financial Performance | Annual Recurring Revenue ARR Added From Acquisitions $101.5M $96.1M $99.1M $93.7M $79.6M $71.1M $73.7M $53.5M +10% +11% +10% +14% +15% +14% +14% +15% Q3/24 Q4/24 Q1/25 Q2/25 Q3/25 Q4/25 Q1/26 Q2/26 Stable Organic Annual Recurring Revenue Growth 13
Slide 14: Financial Performance | Revenue Organic Expansion
Financial Performance | Revenue Organic Expansion Incremental Organic Growth $32.0M $31.4M $31.9M $31.7M Acquired Revenue Base $23.9M $21.7M 51% 50% 51% 50% $20.6M $16.5M 50% 48% 46% 51% 49% 50% 49% 50% 52% 54% 50% 49% Q3/24 Q4/24 Q1/25 Q2/25 Q3/25 Q4/25 Q1/26 Q2/26 Incremental Organic Growth Increa
Slide 15: Financial Performance | Revenue Subscription Mix
Financial Performance | Revenue Subscription Mix $32.0M $31.4M $31.9M $31.7M Recurring Subscription Revenue $23.9M $20.6M $21.7M $16.5M 74% 75% 75% 77% 85% 83% 86% 84% Q3/24 Q4/24 Q1/25 Q2/25 Q3/25 Q4/25 Q1/26 Q2/26 Recurring Subscription Revenue Historically 80% of Revenue 15
Slide 16: Financial Performance | Margin Enhancement
Financial Performance | Margin Enhancement Cash Deployed (Cash Flow Statement) $36.1M Adj. EBITDA margin 28% $22.1M 26% 26% 26% 25% 25% $14.5M 24% 22% Q3/24 Q4/24 Q1/25 Q2/25 Q3/25 Q4/25 Q1/26 Q2/26 Proven Playbook to Drive Margin Expansion After Acquisitions 16
Slide 17: Financial Performance | Profitability
Financial Performance | Profitability 81% 79% 82% 79% Adj. EBITDA $8.0M $8.2M Software Gross Margin Profile $7.4M $7.2M 24% 25% 26% 22% Stable Adj. EBITDA Margin Strong TTM Gross CFO Conversion (1) 47% 62% 72% 79% Q3/25 Q4/25 Q1/26 Q2/26 Q3/25 Q4/25 Q1/26 Q2/26 (1) “Gross CFO” defined as Cash Flow f
Slide 18: Financial Performance | Liquidity and Capitalization
Financial Performance | Liquidity and Capitalization $120M+ $0M 63.4M 15%+ Current Cash (1) Current Debt Common Shares (1) Insider Ownership (2) $5.2M $65M 3.9M 70%+ Average TTM Available Debt Options and DSUs (1) Insider and Institutional Quarterly FCF Capacity No Warrants Ownership (2) (1) As at J
Slide 19: Leadership | Executive Team
Leadership | Executive Team Dan Matlow President & CEO Mike Sanders EVP UK, Europe & Middle East ▪ Over 35 years of experience in technology with a focus on Health IT ▪ Over 20 years of experience in Healthcare Operations Management ▪ Previously CEO & Founder at Medworxx ▪ Previously COO UK & Irelan
Slide 20: Leadership | Board of Directors
Leadership | Board of Directors Dan Matlow President & CEO Barry Tissenbaum, CPA, CA ▪ Over 35 years of experience in technology with a focus on Health IT ▪ Retired former Senior Partner with Ernst & Young ▪ Previously CEO & Founder at Medworxx ▪ Currently serves on the Noranda Income Fund Board ▪ T
Slide 21: Why Invest
Why Invest Compound cash flow growth, drive long-term value 1 2 3 Accretive M&A Cost Optimization ARR Growth Expand platform Leverage offshore Organically grow with technologically, hub and software global penetration operationally, and scale benefits to and cross-sell financially accretive expand c
Slide 22: TSX:VHI OTCQX:VHIBF
Dan Matlow President & CEO dan.matlow@vitalhub.com Brian Goffenberg, CPA, CA CFO & EVP brian.goffenberg@vitalhub.com Christian Sgro, CPA, CA, CFA Head of IR and M&A Specialist christian.sgro@vitalhub.com TSX:VHI OTCQX:VHIBF